Calithera Biosciences, Inc. - CALA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2022 · Q3 2022
Value (USD)
Total reported value ($000)
$2.554M
QoQ value delta ($000)
-$215K (-7.76%)
Implied price effect (QoQ)
+10.74%
Shares
Total shares
784,652
QoQ shares delta
-157,402 (-16.71%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CALA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2022)

Top 25 only Full list
Early Q3 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
PRIMECAP MANAGEMENT CO/CA/ 1,307 401,080 0.0%
CITADEL ADVISORS LLC 649 199,269 0.0%
RENAISSANCE TECHNOLOGIES LLC 218 66,795 0.0%
VANGUARD GROUP INC 153 47,169 0.0%
GEODE CAPITAL MANAGEMENT, LLC 95 29,176 0.0%
JPMORGAN CHASE & CO 79 24,345 0.0%
STATE STREET CORP 35 10,805 0.0%
WELLS FARGO & COMPANY/MN 12 3,782 0.0%
MORGAN STANLEY 2 697 0.0%
GROUP ONE TRADING, L.P. 2 660 0.0%
BANK OF AMERICA CORP /DE/ 1 539 0.0%
UBS Group AG 1 321 0.0%
CITIGROUP INC 0 14 0.0%